3rd Quarter - Termination

OGR for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

Firm
OGR
Client
Income
$50,000
Expenses
—
Terminated
Sep 30, 2012

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R.2529/S.1368, Restoring Access to Medication Act. Issues related to insuring access to over-the-counter drugs and Flexible Spending Accounts/Health Savings Accounts.

LobbyistCovered position, as disclosed
STANTON BULLOCK —
J MICHAEL HOGAN —
GORDON TAYLOR —
STEVE TILTON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1368 (112th), H.R. 2529 (112th)

Medical/Disease Research/Clinical Labs MED

S.3376, PACT Act; issues related to preventing abuse or diversion of over-the-counter drugs; S.3187, Food and Drug Administration Safety and Innovation Act; issues related to insuring access to over-the-counter drugs.

LobbyistCovered position, as disclosed
STANTON BULLOCK —
J MICHAEL HOGAN —
GORDON TAYLOR —
STEVE TILTON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3187 (112th), S. 3376 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.